Cargando…

Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours

Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Levi-Schaffer, Francesca, Mandelboim, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106362/
https://www.ncbi.nlm.nih.gov/pubmed/29066058
http://dx.doi.org/10.1016/j.it.2017.10.001
_version_ 1783512595733413888
author Levi-Schaffer, Francesca
Mandelboim, Ofer
author_facet Levi-Schaffer, Francesca
Mandelboim, Ofer
author_sort Levi-Schaffer, Francesca
collection PubMed
description Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of targeting these receptors in cancer, autoimmune diseases, and allergy. We summarise and emphasise the idea that these receptors, which have evolved in part in response to pathogen pressure, fine-tune the immune response, preserve homeostasis, and that pathogens and tumours use the dominance of the inhibitory receptors over the coactivating receptors to avoid immune elimination. Finally, we discuss the options of using paired receptors and their ligand for immune cell education and therapy.
format Online
Article
Text
id pubmed-7106362
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71063622020-03-31 Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours Levi-Schaffer, Francesca Mandelboim, Ofer Trends Immunol Review Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of targeting these receptors in cancer, autoimmune diseases, and allergy. We summarise and emphasise the idea that these receptors, which have evolved in part in response to pathogen pressure, fine-tune the immune response, preserve homeostasis, and that pathogens and tumours use the dominance of the inhibitory receptors over the coactivating receptors to avoid immune elimination. Finally, we discuss the options of using paired receptors and their ligand for immune cell education and therapy. Elsevier Ltd. 2018-02 2017-10-20 /pmc/articles/PMC7106362/ /pubmed/29066058 http://dx.doi.org/10.1016/j.it.2017.10.001 Text en © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Levi-Schaffer, Francesca
Mandelboim, Ofer
Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title_full Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title_fullStr Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title_full_unstemmed Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title_short Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
title_sort inhibitory and coactivating receptors recognising the same ligand: immune homeostasis exploited by pathogens and tumours
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106362/
https://www.ncbi.nlm.nih.gov/pubmed/29066058
http://dx.doi.org/10.1016/j.it.2017.10.001
work_keys_str_mv AT levischafferfrancesca inhibitoryandcoactivatingreceptorsrecognisingthesameligandimmunehomeostasisexploitedbypathogensandtumours
AT mandelboimofer inhibitoryandcoactivatingreceptorsrecognisingthesameligandimmunehomeostasisexploitedbypathogensandtumours